Correlation Between Veracyte and Dyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Dyne Therapeutics, you can compare the effects of market volatilities on Veracyte and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Dyne Therapeutics.
Diversification Opportunities for Veracyte and Dyne Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Veracyte and Dyne is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Dyne Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Dyne Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 1.87 times less return on investment than Dyne Therapeutics. But when comparing it to its historical volatility, Veracyte is 1.51 times less risky than Dyne Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Dyne Therapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 1,090 in Dyne Therapeutics on September 4, 2024 and sell it today you would earn a total of 1,727 from holding Dyne Therapeutics or generate 158.44% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Dyne Therapeutics
Performance |
| Timeline |
| Veracyte |
| Dyne Therapeutics |
Veracyte and Dyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Dyne Therapeutics
The main advantage of trading using opposite Veracyte and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Dyne Therapeutics vs. Candel Therapeutics | Dyne Therapeutics vs. Cingulate Warrants | Dyne Therapeutics vs. Unicycive Therapeutics | Dyne Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |